Release Date: 2023-09-14

Management of Diabetes Mellitus in Patients in Intensive Care Unit

Gozde Ak (Author)

Release Date: 2023-09-14

Managing diabetes mellitus in patients in the intensive care unit (ICU) requires vigilant monitoring and tailored treatment strategies due to the complexity and critical nature of their medical condition. Close glucose monitoring is essential, often requiring continuous intravenous or frequent point-of-care glucose measurements to maintain tight glycemic control. Insulin therapy is typically the cornerstone, with [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page239
Last Page247
DOIhttps://doi.org/10.69860/nobel.9786053359111.22
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count9
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

Managing diabetes mellitus in patients in the intensive care unit (ICU) requires vigilant monitoring and tailored treatment strategies due to the complexity and critical nature of their medical condition. Close glucose monitoring is essential, often requiring continuous intravenous or frequent point-of-care glucose measurements to maintain tight glycemic control. Insulin therapy is typically the cornerstone, with protocols adjusting doses based on frequent glucose checks to achieve target levels while avoiding hypoglycemia. In ICU settings, stress-induced hyperglycemia is common and may exacerbate pre-existing diabetes. Thus, strategies aim to manage both underlying diabetes and acute stress-related hyperglycemia. Nutrition support is carefully managed to balance glucose control and meet caloric needs, often involving specialized enteral or parenteral nutrition formulations. Furthermore, comorbidities such as infections and cardiovascular issues complicate diabetes management in the ICU, necessitating a multidisciplinary approach involving endocrinologists, intensivists, and specialized nursing teams. Regular reassessment of insulin requirements, adjustment of therapy based on changing clinical conditions, and attention to potential drug interactions are crucial for optimizing outcomes in critically ill patients with diabetes mellitus in the ICU.

Gozde Ak (Author)
MD, Karaman Training and Research Hospital
https://orcid.org/0000-0003-2000-2516

  • IDF Diabetes Atlas 2021, 10th edition https://diabetesatlas.org/atlas/tenth-edition/ (Accessed on January 17, 2022).

  • American Diabetes A. Diagnosis and classifi cation of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1(Suppl 1):S62-9.

  • Wachtel TJ. The diabetic hyperosmolar state. Clin Geriatr Med. 1990;6(4):797-806.

  • Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-43.

  • Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4(9):E7-E14.

  • Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001-9.

  • Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17(2):R37.

  • van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.

  • Ulate KP. A critical appraisal of Vlasselaers D, Milants I, Desmet L, et al: intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009; 373:547-556. Pediatr Crit Care Med. 2011;12(4):455-8.

  • Gunst J, De Bruyn A, Van den Berghe G. Glucose control in the ICU. Curr Opin Anaesthesiol. 2019;32(2):156-62.

  • Investigators N-SS, Finfer S, Chittock DR, Su SY, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.

  • Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med. 2017;43(1):1-15.

  • Association AD. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020;44(Supplement_1):S211-S20.

  • Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663-9.

  • Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40(12):3251-76.

  • Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014;40(7):973-80.

  • Marik PE. Critical illness-related corticosteroid insuffi ciency. Chest. 2009;135(1):181-93.

  • Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;58(5):921-4.

  • Badawi O, Waite MD, Fuhrman SA, Zuckerman IH. Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med. 2012;40(12):3180-8.

  • Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36(8):2249-55.

  • International Hypoglycaemia Study G. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155-7.

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!